Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Katharine Collier"'
Autor:
Yuanquan Yang, Sarah P. Psutka, Anish B. Parikh, Mingjia Li, Katharine Collier, Abdul Miah, Sherry V. Mori, Megan Hinkley, Scott S. Tykodi, Evan Hall, John A. Thompson, Ming Yin
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3106-3114 (2022)
Abstract Background Immune checkpoint inhibitor/tyrosine kinase inhibitor (ICI/TKI) combinations are a new standard of care for the initial treatment of metastatic renal cell carcinoma (mRCC). Their efficacy and toxicity beyond the first‐line setti
Externí odkaz:
https://doaj.org/article/5a0bc07a3300429c841ed05a5967d215
Autor:
Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter J. Ansell, Mark Watson, Junu Bae, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens B. Huober, Mehra Golshan, William M. Sikov, Gunter von Minckwitz, Priya Rastogi, Lang Li, Lijun Cheng, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans, Charles E. Geyer, Sibylle Loibl, Daniel G. Stover
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract In the BrighTNess trial, carboplatin added to neoadjuvant chemotherapy (NAC) was associated with increased pathologic complete response (pCR) rates in patients with stage II/III triple-negative breast cancer (TNBC). In this matched cohort st
Externí odkaz:
https://doaj.org/article/c6af5c9ea1394c7ab85bf5141ac651b6
Autor:
Johanna M. Schafer, Tong Xiao, Hyunwoo Kwon, Katharine Collier, Yuzhou Chang, Hany Abdel-Hafiz, Chelsea Bolyard, Dongjun Chung, Yuanquan Yang, Debasish Sundi, Qin Ma, Dan Theodorescu, Xue Li, Zihai Li
Publikováno v:
iScience, Vol 25, Iss 8, Pp 104717- (2022)
Summary: The cancer research field is finally starting to unravel the mystery behind why males have a higher incidence and mortality rate than females for nearly all cancer types of the non-reproductive systems. Here, we explain how sex – specifica
Externí odkaz:
https://doaj.org/article/0e4fc389c3f74ae1a9fcda8b557bb084
Autor:
Corbin J. Eule, Junxiao Hu, Sulaiman Al-Saad, Katharine Collier, Patrick Boland, Akeem R. Lewis, Rana R. McKay, Vivek Narayan, Dominick Bosse, Amir Mortazavi, Tracy L. Rose, Brian A. Costello, Alan H. Bryce, Elaine T. Lam
Publikováno v:
Clinical Genitourinary Cancer.
Autor:
Deborah Caddy, Sarah Matthes, Emily E. Spence, Ashvita Garg, Erika L. Thompson, Katharine Collier Esser, Danielle Rohr
Publikováno v:
American Journal of Health Behavior. 45:947-955
Objective: School-based child abuse primary prevention programs are delivered across the country; however, a validated measurement tool that is feasible to deliver to students is unavailable. The purpose of this study was to describe the development
Autor:
Mina S. Makary, Long-Sheng Chang, Katharine Collier, D. Bradley Welling, Beth A. Miles-Markley, Edina Shu, Craig C. Hofmeister, H. Wayne Slone, S. Alireza Mansouri, Brian A. Neff, Janet L. Oblinger, Jaishri O. Blakeley, Robert K. Jackler, Sarah S. Burns, Amir Mortazavi
Publikováno v:
Laryngoscope Investigative Otolaryngology
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 1008-1019 (2021)
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 1008-1019 (2021)
Objectives Two pilot studies of AR‐42, a pan‐histone deacetylase inhibitor, in human neurofibromatosis type 2 (NF2), vestibular schwannomas (VS), and meningiomas are presented. Primary endpoints included safety, and intra‐tumoral pharmacokineti
Autor:
Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier, Zachary T. Weber, Tejas R. Jammihal, Katrina Z. Kao, Edward T. Richardson, Tanya Keenan, Ofir Cohen, Michael P. Manos, Ryan C. Brennick, Patrick A. Ott, F. Stephen Hodi, Deborah A. Dillon, Victoria Attaya, Tess O'Meara, Nancy U. Lin, Eliezer M. Van Allen, Scott Rodig, Eric P. Winer, Elizabeth A. Mittendorf, Catherine J. Wu, Nikhil Wagle, Daniel G. Stover, Sachet A. Shukla, Sara M. Tolaney
Publikováno v:
JCO Precis Oncol
PURPOSE In metastatic triple-negative breast cancer (mTNBC), consistent biomarkers of immune checkpoint inhibitor (ICI) therapy benefit remain elusive. We evaluated the immune, genomic, and transcriptomic landscape of mTNBC in patients treated with I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7fa82e75f5dc38813689b7ca3c1bdb4
https://europepmc.org/articles/PMC9848556/
https://europepmc.org/articles/PMC9848556/
Autor:
Samuel S. Freeman, Heather A. Parsons, Daniel G. Stover, Zachary Weber, Elizabeth H. Stover, Sarah Asad, Viktor A. Adalsteinsson, Gavin Ha, Sara M. Tolaney, David Tallman, Sachet A. Shukla, Justin Rhoades, Katharine Collier, Romualdo Barroso-Sousa, Juliet Forman, Haider Mahdi, Carrie Cibulskis, Nicole Williams, Niall J. Lennon
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-17 (2021)
Genome Medicine
Genome Medicine
BackgroundCirculating tumor DNA (ctDNA) offers minimally invasive means to repeatedly interrogate tumor genomes, providing opportunities to monitor clonal dynamics induced by metastasis and therapeutic selective pressures. In metastatic cancers, ctDN
Autor:
Lijun Cheng, Mathew Cherian, W. Fraser Symmans, Charles E. Geyer, Jens Huober, Sarah Asad, Katharine Collier, Daniel G. Stover, Michael Untch, Mark A. Watson, William M. Sikov, Carsten Denkert, Peter Ansell, Sibylle Loibl, Priya Rastogi, David Maag, Gunter von Minckwitz, Junu Bae, Joyce O'Shaughnessy, Norman Wolmark, Lang Li, Mehra Golshan, Hope S. Rugo, Otto Metzger-Filho
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
In the BrighTNess trial, carboplatin added to neoadjuvant chemotherapy (NAC) was associated with increased pathologic complete response (pCR) rates in patients with stage II/III triple-negative breast cancer (TNBC). In this matched cohort study, case
Autor:
Steven K. Clinton, Amir Mortazavi, Abdul Miah, Evan Gross, Edmund Folefac, Evan T. Hall, Katharine Collier, Kaylee Oliva, Paul Monk, Megan Hinkley, Yuanquan Yang, John F. Thompson, John C. Gore, Delaney Orcutt, Joel Kramer, Duncan Hussey, Mingjia Li, Sherry Mori-Vogt, George R. Schade, Scott S. Tykodi, Sarah P. Psutka, Anish B. Parikh, Elliot Trott, Ming Yin, Daniel W. Lin
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The role of CN in the treatment of mRCC has been questioned with the recent approval of novel systemic therapy (ST) agents and the results of the CARMENA trial. Our objec...